In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2026-04-01
DOI
https://doi.org/10.7326/annals-26-00802-jc
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk

Gary M. Onady
Annals of Internal Medicine
Attention Deficit Hyperactivity Disorder
article

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk

Gary M. Onady
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 179(4)
University of Cincinnati Medical Center (US)
Good health and well-being
Openalex Percentile: Top 22%
Attention Deficit Hyperactivity Disorder
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk — Gary M. Onady · Annals of Internal Medicine (2026) | TGRS Research Map | TGRS